In8bio shares rise 10.11% premarket after director Jeremy Graff buys 2,500 shares.

miércoles, 3 de diciembre de 2025, 8:19 am ET1 min de lectura
INAB--
IN8bio surged 10.11% in premarket trading following its announcement to participate in the 2023 Cantor Fitzgerald Global Healthcare Conference on September 20 at 8:27 AM. This event, disclosed during the premarket session, likely boosted investor confidence by highlighting the company’s visibility and strategic engagement with.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios